What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News The solidarity challenge to find a cure for GNB1 encephalopathy achieves its first goal raising more than €50,000 The micro-donation initiative is being carried out by Marc León, together with the relatives of the patients, for a research project in gene therapy headed by Dr. Miguel Chillón. News Dr. María José Soler, elected editor-in-chief of the Clinical Kidney Journal Dr. María José Soler, nephrologist at Vall d'Hebron and the VHIR, will become, in June 2022, the first editor-in-chief of the specialized journal Clinical Kidney Journal. News Vall d'Hebron participates in the largest study on non-rhabdomyosarcoma type paediatric soft tissue sarcomas The pediatric surgeon Gabriela Guillén is a co-author in this study of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) that lays the foundations for the treatment of this type of tumors. News Vall d'Hebron publishes four innovative works on different systemic diseases Articles from the Systemic Diseases research group at the VHIR focus on scleroderma, antiphospholipid syndrome, Sjögren's syndrome, and the relationship between cancer and inflammatory myopathy. News Ona Futura Foundation donates €40,000 for research on immune disorders related to pregnancy in Vall d’Hebron Ona Futura Foundation has signed a donation agreement with the Vall d'Hebron Research Institute (VHIR) to contribute to research on various immune disorders related to the pregnancy process. News Dr. Antoni Soriano, awarded by the European Society of Paediatric Infectious Diseases (ESPID) The VHIR researcher has been recognized for his research on the low transmissibility of COVID-19 from pediatric patients. News Vall d'Hebron leads a multicenter study that will assess a faster workflow for the management of patients with stroke The international multi-centric study WE-TRUST will assess the impact of the "Direct to Angiography" approach thanks to a computed tomography technology developed and improved by Philips. News Una nova calculadora per predir la mortalitat en pacients amb endocarditis infecciosa podria salvar vides L'eina està disponible online i permet ajudar a la presa de decisions mèdiques en pacients amb endocarditis infecciosa sotmesos a cirurgia cardíaca, una operació d'alt risc. News A new project seeks to extend nucleoside therapy to different mitochondrial disorders CIBERER and CIBEREHD will study the possible extension of therapy based on the administration of deoxyribonucleosides to other disorders characterized by problems in the replication of mitochondrial DNA. News Vall d'Hebron advances in the knowledge of the biological causes of Dent's disease The CIBBIM-Nanomedicine-Renal Pathophysiology group of the VHIR has developed renal cell models to investigate the pathophysiological mechanisms and help provide new drugs for the treatment of this disease. News Vall d’Hebron, UAB and UPC design an app to help assess the severity of symptoms in chronic fatigue syndrome Researchers have shown that heart rate variability is related to the severity of fatigue in women with chronic fatigue syndrome / myalgic encephalomyelitis. News Vall d’Hebron participa en la creació d’un nou sistema per identificar nòduls indicadors de possibles càncers pulmonars amb Intel·ligència Artificial Aquesta eina ha estat desenvolupada per Eurecat amb la col.laboració del Campus Vall d'Hebron coordinada pel Servei de Diagnòstic per la Imatge de l'Hospital, en el marc del projecte Deep Lung. News Mutua Madrileña Foundation grants two Vall d'Hebron projects Dr. Javier Torres and Dr. Alberto Sandiumenge lead the selected works in the field of rare diseases and transplantation. News Two VHIR researchers have received awards at the Catalan Health Institute's 2021 Research Awards Vall d’Hebron University Hospital hosted the Catalan Institute of Health's (ICS) Research Conference earlier today, where the 2020 and 2021 ICS Research Awards were presented. News Kevin Arias is awarded at the X UAB Doctoral Workshop for the invention of a simpler malaria detection device The new device, much simpler and more immediate than current techniques, would generate results in 20 minutes and detect malaria in the most remote regions of the planet. News Vall d'Hebron demonstrates that the gut microbiota can facilitate the diagnosis of Crohn's disease and ulcerative colitis The quantification of the gut microbiota, combined with clinical data, would be useful to facilitate the correct diagnosis of patients and offer them the appropriate treatment for their pathology and also to prevent the appearance of flares. News Vall d'Hebron demonstrates that the gut microbiota can facilitate the diagnosis of Crohn's disease and ulcerative colitis The quantification of the gut microbiota, combined with clinical data, would be useful to facilitate the correct diagnosis of patients and offer them the appropriate treatment for their pathology and also to prevent the appearance of flares. News Researcher Alba Torija, awarded for the best oral communication for the analysis of the cells involved in the rejection of solid organs The advances, led by the VHIR Nephrology group, have been presented at the XVI Congress of the Catalan Transplantation Society. News Vall d'Hebron and IDIAP Jordi Gol collaborate in pediatric research in primary care The joint work has received a runner-up prize for the best Oral Communication from the Catalan Pediatric Society. News Endolipid Therapeutics, the spin-off of Vall d’Hebron and GENESIS Ventures, emerges to develop a new strategy to reduce visceral and subcutaneous fat Endolipid Therapeutics has developed a new approach to reducing visceral fat with therapeutic applications to treat, for example, fatty liver, and applications will be developed to reduce subcutaneous fat. Pagination First page « Previous page ‹ … Page 55 Page 56 Current page 57 Page 58 Page 59 … Next page › Last page »
